Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
PremiumPress ReleasesMersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results
1M ago
MRSN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
MRSN Earnings this Week: How Will it Perform?
1M ago
Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
Premium
Press Releases
Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024
1M ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesMersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5M ago
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
Premium
Press Releases
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024
5M ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6M ago
Guggenheim upgrades Mersana Therapeutics on XMT-1660 potential
PremiumThe FlyGuggenheim upgrades Mersana Therapeutics on XMT-1660 potential
7M ago
Bad News for Mersana Therapeutics Stock: This New Risk Has Been Added
Premium
Company Announcements
Bad News for Mersana Therapeutics Stock: This New Risk Has Been Added
7M ago
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Neutral at Guggenheim
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100